Page 5 - Sun Pharma

Here's why Vinay Rajani of HDFC Securities is bullish on GSFC, Sun Pharma

The technical analyst expects the Nifty to turn bearish below 16,555; whereas on the upside sees resistance around 16,927 and 17,040 levels.

Sensex rises for 2nd day, surges 1,223 pts; Nifty tops 16,300; RIL zooms 5%

CLOSING BELL: Ukrainian President Volodymyr Zelenskyy's reported statement that his country has cooled down on the question of a NATO membership calmed investor nerves

Stocks to Watch: MTNL, Sun Pharma, Airlines, Adani Ports, Bharat Forge

MTNL is in focus as the Centre is considering relaxing some norms that led to the failure in attracting bids for assets of BSNL and MTNL as they look to restart the auction for their non-core assets.

Investors' wealth jumps over Rs 2.51 trillion as stocks rebound

Sun Pharma the biggest gainer among Sensex firms with a jump of 3.99 per cent, followed by TCS, NTPC, Wipro, Tech Mahindra, Dr Reddy's, UltraTech Cement and Infosys

Stocks to Watch: Aurobindo, Sun Pharma, Future Retail, Vedanta, Voda Idea

Shares of Adani Power are likely to be in focus as the company received a favourable verdict from the Supreme Court against power discoms in Rajasthan.

Aurobindo, Sun Pharma recall products in US market for defaulting norms

Leading homegrown drug makers Aurobindo Pharma and Sun Pharmaceutical Industries are recalling different products in the US market due to deviation from standard manufacturing norms.

Pharma industry likely to grow to $130 billion by 2030: Industry leaders

'As India becomes an increasingly more important component for the global supply chain, that should benefit the industry going forward,' Sun Pharma Managing Director Dilip Shanghvi said

Fag-end selling drags Sensex for 6th day, dips 69 pts; RIL slips 1%

Closing Bell: The frontline S&P BSE Sensex fell 69 points to settle at 57,232 levels while the Nifty50 shut shop at 17,063 down 29 points

Stocks to Watch: Mahindra CIE, Dilip Buildcon, SIS, Butterfly Gandhimathi

Stocks like Sun Pharma, Dr.Reddy's and others having exposure to Europe are likel to be in focus as the Russia-Ukraine crisis deepens.

Stocks to Watch: DRL, Mankind, Sun Pharma, Wipro, Kalpataru, TTML, Airlines

Ambuja Cement, Nestle India and Veritas to announce December quarter results today.

Sun Pharma hits six year-high; gains 13% in last eight days on strong Q3

In Q3, the company has witnessed stronger growth than anticipated in the US, Emerging Markets and RoW.

Market wrap: Bulls cheer Budget 2022; Sensex, Nifty end 1.4% higher

Nifty Metal index soars 4%; Tata Steel, SAIL rally; ITC jumps to 7-week high as no tobacco tax relieves investors; Sun Pharma hits new 52-week high post Q3 results; Govt brings cryptos under tax net

Sun Pharma rallies 5%, hits new 52-week high post Q3 results

The management said the company achieved a sustained momentum and good growth across businesses; despite rising costs, achieved higher profitability.

Stocks to Watch: Sun Pharma, UPL, DLF, DB Realty, OMCs, Tata group

Adani Ports, Indian Hotels and Tech Mahindra are some of the prominent companies to announce results today.

Sun Pharma Q3 results: Net profit rises 11% to Rs 2,058.8 crore

In Q3, the revenue from specialty products came in at $183 million, up 21 per cent YoY

Sensex ends 814 pts higher ahead of Budget-day in broad-based rally

Large part of today's rally in the headline indices was led by IT stocks such Tech M, Wipro, Infosys and HCL Tech; financials such as Bajaj twins and SBI, and index heavyweights RIL

Sun Pharma Q3 results: Net profit rises 11% to Rs 2,059 cr

Total revenue from operations rose to Rs 9,863 cr in the third quarter as compared to Rs 8,836.7 cr in the same period of previous fiscal

Sun Pharma-arm Taro logs better-than-expected Q3 Ebitda margin; stock up 4%

In Q3FY22, Taro's EBITDA margins improved 108 bps year-on-year (YoY) to 31.3 per cent mainly due to better gross margins.

Sun Pharma launches dry eye treatment product in Canada

This launch is an important milestone for the drugmaker as it expands its ophthalmics portfolio into Canada, the firm said

Bharti Airtel, L&T, M&M among top trading bets ahead of Budget 2022

Major stocks have broken out on upside, any trigger in Budget 2022 could see sharp up move